Cargando…
Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays
Deficiency of dihydropyrimidine dehydrogenase (DPD), encoded by the DPYD gene, is associated with severe toxicity induced by the anti-cancer drug 5-Fluorouracil (5-FU). DPYD genotyping of four recommended polymorphisms is widely used to predict toxicity, yet their prediction power is limited. Increa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694733/ https://www.ncbi.nlm.nih.gov/pubmed/36430399 http://dx.doi.org/10.3390/ijms232213923 |
_version_ | 1784837878084272128 |
---|---|
author | De Luca, Ottavia Salerno, Gerardo De Bernardini, Donatella Torre, Maria Simona Simmaco, Maurizio Lionetto, Luana Gentile, Giovanna Borro, Marina |
author_facet | De Luca, Ottavia Salerno, Gerardo De Bernardini, Donatella Torre, Maria Simona Simmaco, Maurizio Lionetto, Luana Gentile, Giovanna Borro, Marina |
author_sort | De Luca, Ottavia |
collection | PubMed |
description | Deficiency of dihydropyrimidine dehydrogenase (DPD), encoded by the DPYD gene, is associated with severe toxicity induced by the anti-cancer drug 5-Fluorouracil (5-FU). DPYD genotyping of four recommended polymorphisms is widely used to predict toxicity, yet their prediction power is limited. Increasing availability of next generation sequencing (NGS) will allow us to screen rare variants, predicting a larger fraction of DPD deficiencies. Genotype–phenotype correlations were investigated by performing DPYD exon sequencing in 94 patients assessed for DPD deficiency by the 5-FU degradation rate (5-FUDR) assay. Association of common variants with 5-FUDR was analyzed with the SNPStats software. Functional interpretation of rare variants was performed by in-silico analysis (using the HSF system and PredictSNP) and literature review. A total of 23 rare variants and 8 common variants were detected. Among common variants, a significant association was found between homozygosity for the rs72728438 (c.1974+75A>G) and decreased 5-FUDR. Haplotype analysis did not detect significant associations with 5-FUDR. Overall, in our sample cohort, NGS exon sequencing allowed us to explain 42.5% of the total DPD deficiencies. NGS sharply improves prediction of DPD deficiencies, yet a broader collection of genotype–phenotype association data is needed to enable the clinical use of sequencing data. |
format | Online Article Text |
id | pubmed-9694733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96947332022-11-26 Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays De Luca, Ottavia Salerno, Gerardo De Bernardini, Donatella Torre, Maria Simona Simmaco, Maurizio Lionetto, Luana Gentile, Giovanna Borro, Marina Int J Mol Sci Article Deficiency of dihydropyrimidine dehydrogenase (DPD), encoded by the DPYD gene, is associated with severe toxicity induced by the anti-cancer drug 5-Fluorouracil (5-FU). DPYD genotyping of four recommended polymorphisms is widely used to predict toxicity, yet their prediction power is limited. Increasing availability of next generation sequencing (NGS) will allow us to screen rare variants, predicting a larger fraction of DPD deficiencies. Genotype–phenotype correlations were investigated by performing DPYD exon sequencing in 94 patients assessed for DPD deficiency by the 5-FU degradation rate (5-FUDR) assay. Association of common variants with 5-FUDR was analyzed with the SNPStats software. Functional interpretation of rare variants was performed by in-silico analysis (using the HSF system and PredictSNP) and literature review. A total of 23 rare variants and 8 common variants were detected. Among common variants, a significant association was found between homozygosity for the rs72728438 (c.1974+75A>G) and decreased 5-FUDR. Haplotype analysis did not detect significant associations with 5-FUDR. Overall, in our sample cohort, NGS exon sequencing allowed us to explain 42.5% of the total DPD deficiencies. NGS sharply improves prediction of DPD deficiencies, yet a broader collection of genotype–phenotype association data is needed to enable the clinical use of sequencing data. MDPI 2022-11-11 /pmc/articles/PMC9694733/ /pubmed/36430399 http://dx.doi.org/10.3390/ijms232213923 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article De Luca, Ottavia Salerno, Gerardo De Bernardini, Donatella Torre, Maria Simona Simmaco, Maurizio Lionetto, Luana Gentile, Giovanna Borro, Marina Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays |
title | Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays |
title_full | Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays |
title_fullStr | Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays |
title_full_unstemmed | Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays |
title_short | Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays |
title_sort | predicting dihydropyrimidine dehydrogenase deficiency and related 5-fluorouracil toxicity: opportunities and challenges of dpyd exon sequencing and the role of phenotyping assays |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694733/ https://www.ncbi.nlm.nih.gov/pubmed/36430399 http://dx.doi.org/10.3390/ijms232213923 |
work_keys_str_mv | AT delucaottavia predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays AT salernogerardo predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays AT debernardinidonatella predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays AT torremariasimona predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays AT simmacomaurizio predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays AT lionettoluana predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays AT gentilegiovanna predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays AT borromarina predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays |